Woo, Peter Y M <br/><br/>
Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.  [electronic resource] 

 -  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia  May 2019 
 - 134-141 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1532-2653 
<br/><br/><label>Standard No.: </label>10.1016/j.jocn.2019.01.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Brain Neoplasms--diagnostic imaging<br/>Chemoradiotherapy, Adjuvant<br/>Cohort Studies<br/>Female<br/>Glioblastoma--diagnostic imaging<br/>Humans<br/>Kaplan-Meier Estimate<br/>Karnofsky Performance Status<br/>Magnetic Resonance Imaging<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Retrospective Studies<br/>Temozolomide--therapeutic use<br/>Tumor Burden<br/>Young Adult